Optimization & characterization of glipizide oral suspension formulation (Record no. 99552)

MARC details
000 -LEADER
fixed length control field 04163ntm a2200373 i 4500
003 - CONTROL NUMBER IDENTIFIER
control field MY-KuUP
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20251125110741.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field t||||fr|||| 000 0
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field ta
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 230614t20232023my a|||fr|||| 000 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number THE0009664 (Local)
Qualifying information Hardback
040 ## - CATALOGING SOURCE
Original cataloging agency UMP
Language of cataloging eng
Transcribing agency UMP
Description conventions rda
090 ## - LOCALLY ASSIGNED LC-TYPE CALL NUMBER (OCLC); LOCAL CALL NUMBER (RLIN)
Classification number (OCLC) (R) ; Classification number, CALL (RLIN) (NR) FTKKP .M88 2023 r Thesis
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Kalaiarasan Muthusamy,
Relator term author.
245 10 - TITLE STATEMENT
Title Optimization & characterization of glipizide oral suspension formulation
Statement of responsibility, etc. Kalaiarasan Muthusamy
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture Kuantan, Pahang :
Name of producer, publisher, distributor, manufacturer UMP,
Date of production, publication, distribution, manufacture, or copyright notice 2023
264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice ©2023
300 ## - PHYSICAL DESCRIPTION
Extent xvi, 175 pages :
Other physical details illustrations (some color) ;
Dimensions 30 cm. +
Accompanying material 1 CD-ROM
336 ## - CONTENT TYPE
Source rdacontent
Content type term text
336 ## - CONTENT TYPE
Source rdacontent
Content type term text
337 ## - MEDIA TYPE
Source rdamedia
Media type term unmediated
337 ## - MEDIA TYPE
Source rdamedia
Media type term computer
338 ## - CARRIER TYPE
Source rdacarrier
Carrier type term volume
338 ## - CARRIER TYPE
Source rdacarrier
Carrier type term computer disc
347 ## - DIGITAL FILE CHARACTERISTICS
Source rda
File type text file
Encoding format PDF
500 ## - GENERAL NOTE
General note Faculty of Chemical and Process Engineering Technology
502 ## - DISSERTATION NOTE
Dissertation note Thesis (Master of Science) -- Universiti Malaysia Pahang – 2023
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc. note Includes bibliographical references
520 3# - SUMMARY, ETC.
Summary, etc. Glipizide is an anti-diabetic medication which belongs to a class of drugs known as sulfonylurea. It is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Glipizide can be a better alternative for metformin as an anti- hyperglycemic drug as it is more efficient in a smaller amount and imposes lesser side effects. Therefore, glipizide was used to make an anti- hyperglycemic drug suspension. In glipizide suspension, there are parameters like native starch, sodium carboxymethyl cellulose and Polysorbate 80 affecting its physical characteristics. There is a high chance for these parameters to interface and influence each other's effects on the suspension. Hence, it is essential to utilize an optimization method that can quantify the relationship between those two parameters, so that their amount in the suspension can be determined to make it perfect and optimum. Response Surface Methodology (RSM) is a combination of statistical and mathematical methods commonly used in the food industry to quantify the impacts of a few factors and to optimize conditions and thus applied in this study to optimize the production of glipizide suspension. In this study, preparation of suspension with parameters such as sodium CMC, native starch and Polysorbate 80 was investigated. The responses involved were viscosity and sedimentation rate. One Factor at One Time method was used to obtain the ranges for the aforementioned parameters. Then, using Design Expert software, the ranges of the parameters were entered in the Central Composite Design (CCD) to create 20 different combinations of parameters for formulation. After conducting the formulation, the values of viscosity and sedimentation rate obtained were keyed in Response Surface Methodology (RSM) for optimization. An optimum suspension was formulated and tested for sedimentation rate, mean particle diameter, viscosity, zeta potential measurement, in-vitro drug release and accelerated stability. Viscosity had an r2 value of 0.1633 and p value of 0.8510; whereas for sedimentation, r2 value was 0.0759 and p value was 0.9780. The sedimentation volume and viscosity of suspension are 0.0047462ml and 0.0039171Ns/m2 respectively. Zeta potential value is -38.63mV. During in-vitro drug release studies, the percentage of drug release is 98.80% after an hour. In conclusion, there is no significant effect on suspension due to individual parameters and their interactions. This study can be improvised by including in-vivo drug release study as well as changing the dosage form to nanoparticles. In-vivo drug release test will provide vi more information on the characteristics of the suspension whereas nanoparticles dosage form will help to reduce the quantity and toxicity of glipizide as well as increase its safety and efficacy.
610 20 - SUBJECT ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element Faculty of Chemical and Process Engineering Technology
General subdivision Dissertations
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Universities and colleges
General subdivision Dissertations
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Theses
General subdivision Dissertations
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Library of Congress Classification
Koha item type Thesis
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Collection Home library Current library Date acquired Total checkouts Full call number Barcode Date last seen Copy number Price effective from Koha item type
  Not lost Library of Congress Classification   Not for loan Reference UMPLIB GAMBANG UMPLIB GAMBANG 14/06/2023   FTKKP .M88 2023 r Thesis T000002398 14/06/2023 1 14/06/2023 Thesis
  Not lost Library of Congress Classification   In Transit   UMPLIB GAMBANG UMPLIB GAMBANG 14/06/2023   CD13364 T000002399 14/06/2023 1 14/06/2023 Thesis

Perpustakaan Universiti Malaysia Pahang Al-Sultan Abdullah
26600 Pekan, Pahang Darul Makmur
Phone: +609 431 5063 (Gambang) / +609 431 5035 (Pekan)
Email: umplibrary@umpsa.edu.my

Connect With Us